Return to List
Study Summary
No.
2005-0872:
.......
Head And Neck
......
Ann M. Gillenwater
......
Head/Neck Surgery
.
Study Summary Title
Study Summary
Number:
2005-0872
Study Title:
An Exploratory Study on Optical Assessment of Oral Mucositis
.
Physician
New Patient Referral
Name:
Ann M. Gillenwater
Patients Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:
Head/Neck Surgery
Referring MD
Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:
713-792-6920
Contact us about clinical trials
.
General Information
Disease Group:
Head And Neck
Supported By:
N/A
Phase of Study:
N/A
Return
Visit:
One visit weekly during radiation therapy (average 6-7 weeks)
Treatment
Agents:
None
Home Care:
N/A
Treatment Loc:
Only at MDACC
Estimated
Length of Stay
in Houston:
N/A
Description/
Intervention:
The goal of this clinical research study is to look for tissue changes inside
the mouth during radiation using new technologies called optical coherence
tomography and fluorescence spectroscopy.
.
Study Objectives / Outcomes
1. To assess the tolerability of performing optical coherence tomography and/or optical spectroscopy in patients with acute oral mucositis.
2. To determine the feasibility of obtaining optical coherence tomography images and/or fluorescence excitation emission matrices from normal and affected sites in patients with acute oral mucositis.
3. To compare optical data obtained with optical coherence tomography and/or spectroscopy with the clinical appearance and scoring of oral mucositis lesions.
.
Study Status Information
Study Activation / Registration Date:
03/23/2006
IRB Review and Approval Date:
01/18/2006
Study Type:
Not Applicable
Recruitment Status:
Terminated
Projected Accrual:
N/A
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you.
Please Contact the
Referral Office
for more information.
Inclusion Criteria:
1) Patients greater than 18 years old.
2) Patients undergoing radiation therapy or chemoradiotherapy for head and neck cancer treatment.
3) Subject must sign an informed consent indicating awareness of the investigational nature of this study.
Exclusion Criteria:
1) NONE
.
Links
Registration Number:
NCT00488332
Study Information on Clinical Trials Registry (clinicaltrials.gov)
Other Links:
.
Results
Return to Clinical Trials at M.D. Anderson Cancer Center